These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3561632)

  • 41. Local low-dose streptokinase thrombolysis of a thrombosed arteriovenous fistula.
    Minar E; Zazgornik J; Marosi L
    Am J Nephrol; 1984; 4(1):66-7. PubMed ID: 6731502
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnosis and management of subclavian vein thrombosis occurring in association with subclavian cannulation for hemodialysis.
    Brady HR; Fitzcharles B; Goldberg H; Huraib S; Richardson T; Simons M; Uldall PR
    Blood Purif; 1989; 7(4):210-7. PubMed ID: 2528361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes.
    Lee T; Barker J; Allon M
    Am J Kidney Dis; 2005 Sep; 46(3):501-8. PubMed ID: 16129212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful use of low dose r-hirudin (Refludan) for recurrent dialysis catheter thrombosis in a patient with heparin induced thrombocytopenia.
    Patel VB; Snyder J; Shopnick RI
    Thromb Haemost; 1999 Sep; 82(3):1205-6. PubMed ID: 10494796
    [No Abstract]   [Full Text] [Related]  

  • 45. New technology: heparin and antimicrobial-coated catheters.
    Ibeas-Lopez J
    J Vasc Access; 2015; 16 Suppl 9():S48-53. PubMed ID: 25751551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Can one treat intravascular thromboses with thrombolytics without risk?].
    Josso F; Dreyfus B; Samama M; Péquignot H
    Presse Med (1893); 1968 May; 76(22):1067-70. PubMed ID: 5648679
    [No Abstract]   [Full Text] [Related]  

  • 47. [Biochemical and pharmacological principles of antithrombotic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):293-312. PubMed ID: 63418
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute bilateral renal artery occlusion: successful revascularization with streptokinase.
    Pilmore HL; Walker RJ; Solomon C; Packer S; Wood D
    Am J Nephrol; 1995; 15(1):90-1. PubMed ID: 7872372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Managing catheter dysfunction for better patient outcomes: a team approach.
    Dinwiddie LC
    Nephrol Nurs J; 2004; 31(6):653-60, 671; quiz 661-2. PubMed ID: 15686329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction.
    Little MA; Walshe JJ
    Am J Kidney Dis; 2002 Jan; 39(1):86-91. PubMed ID: 11774106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacologic treatment of catheter-related thrombus in pediatrics.
    Ruble K; Long C; Connor K
    Pediatr Nurs; 1994; 20(6):553-7. PubMed ID: 7708454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal artery thrombosis occurring in an adult with the idiopathic nephrotic syndrome: results of local treatment with streptokinase.
    Temes Montes XL; Almaraz Jiménez MA; Lorenzo Aguiar MD; Martínez Ara J; Sanz Guajardo A; Miguel Alonso JL; San Martín P; Sánchez Sicilia L
    Clin Nephrol; 1979 Aug; 12(2):90-2. PubMed ID: 527274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of oral anticoagulants to prevent central venous catheter-related thrombosis in hemodialysis].
    Mandolfo S; Gallieni M
    G Ital Nefrol; 2010; 27(5):490-7. PubMed ID: 20922680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Thrombotic occlusion of the abdominal aorta in the neonatal period--successful thrombolytic treatment].
    Kaulitz R; Luhmer I; Wilken M; Kallfelz HD
    Klin Padiatr; 1992; 204(3):141-4. PubMed ID: 1614178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of different catheter lock strategies on bacterial colonization of permanent central venous hemodialysis catheters.
    Erb S; Widmer AF; Tschudin-Sutter S; Neff U; Fischer M; Dickenmann M; Grosse P
    Infect Control Hosp Epidemiol; 2013 Dec; 34(12):1314-7. PubMed ID: 24225618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous streptokinase for thrombolysis of occluded arteriovenous access. Its use in patients undergoing hemodialysis.
    Goldberg JP; Contiguglia SR; Mishell JL; Klein MH
    Arch Intern Med; 1985 Aug; 145(8):1405-8. PubMed ID: 4026471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The theory and practice of streptokinase therapy].
    Dahlström H
    Z Gesamte Inn Med; 1965 Dec; 20(23):709-12. PubMed ID: 5872320
    [No Abstract]   [Full Text] [Related]  

  • 58. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator.
    Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
    Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Thrombolysis for the removal of thrombotic obliteration of the Cimino shunt in hemodialysis patients].
    Koestering H; Mietzsch G; Wigger W; Wittich KA; Scheler F
    Med Klin; 1972 Jul; 67(27):945-8. PubMed ID: 5048692
    [No Abstract]   [Full Text] [Related]  

  • 60. [Eighteen years' experience of thrombolytic therapy with streptokinase (author's transl)].
    Hess H
    MMW Munch Med Wochenschr; 1980 Nov; 122(48):1735-8. PubMed ID: 6779140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.